Free Trial
NASDAQ:ZLAB

Zai Lab (ZLAB) Stock Price, News & Analysis

Zai Lab logo
$32.18 -0.38 (-1.16%)
As of 01:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Zai Lab Stock (NASDAQ:ZLAB)

Key Stats

Today's Range
$31.79
$32.47
50-Day Range
$32.56
$40.51
52-Week Range
$18.60
$44.34
Volume
497,069 shs
Average Volume
955,779 shs
Market Capitalization
$3.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.35
Consensus Rating
Moderate Buy

Company Overview

Zai Lab Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

ZLAB MarketRank™: 

Zai Lab scored higher than 46% of companies evaluated by MarketBeat, and ranked 597th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zai Lab has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Zai Lab has only been the subject of 3 research reports in the past 90 days.

  • Read more about Zai Lab's stock forecast and price target.
  • Earnings Growth

    Earnings for Zai Lab are expected to grow in the coming year, from ($2.58) to ($1.74) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zai Lab is -15.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zai Lab is -15.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zai Lab has a P/B Ratio of 4.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Zai Lab's valuation and earnings.
  • Percentage of Shares Shorted

    4.33% of the float of Zai Lab has been sold short.
  • Short Interest Ratio / Days to Cover

    Zai Lab has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Zai Lab has recently increased by 14.82%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Zai Lab does not currently pay a dividend.

  • Dividend Growth

    Zai Lab does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.33% of the float of Zai Lab has been sold short.
  • Short Interest Ratio / Days to Cover

    Zai Lab has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Zai Lab has recently increased by 14.82%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Zai Lab has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Zai Lab this week, compared to 6 articles on an average week.
  • Search Interest

    Only 2 people have searched for ZLAB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zai Lab insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,878,224.00 in company stock.

  • Percentage Held by Insiders

    Only 4.96% of the stock of Zai Lab is held by insiders.

  • Percentage Held by Institutions

    41.65% of the stock of Zai Lab is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zai Lab's insider trading history.
Receive ZLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zai Lab and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZLAB Stock News Headlines

Chase, Bank of America, Wells Fargo Preparing for BIG Change
Thanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in America could soon begin to replace every single dollar in your bank account… With a better, more technologically advanced dollar… Potentially making a lot of people rich in the process.tc pixel
Zai Lab (NASDAQ:ZLAB) Trading Down 5.9% on Insider Selling
Zai Lab Establishes Oncology Scientific Advisory Board
See More Headlines

ZLAB Stock Analysis - Frequently Asked Questions

Zai Lab's stock was trading at $26.19 at the start of the year. Since then, ZLAB shares have increased by 22.8% and is now trading at $32.17.

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) announced its quarterly earnings data on Thursday, August, 7th. The company reported ($0.37) EPS for the quarter, meeting analysts' consensus estimates of ($0.37). The company earned $109.98 million during the quarter, compared to analysts' expectations of $125.66 million. Zai Lab had a negative net margin of 49.68% and a negative trailing twelve-month return on equity of 27.32%.
Read the conference call transcript
.

Zai Lab (ZLAB) raised $100 million in an IPO on Wednesday, September 20th 2017. The company issued 5,900,000 shares at $16.00-$18.00 per share. J.P. Morgan, Citigroup and Leerink Partners served as the underwriters for the IPO.

Top institutional shareholders of Zai Lab include Jane Street Group LLC, Jefferies Financial Group Inc. and Group One Trading LLC. Insiders that own company stock include Ying Du, Joshua L Smiley, Harald Reinhart, Rafael Amado, William Lis, Frazor Titus Edmondson III and Yajing Chen.
View institutional ownership trends
.

Shares of ZLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zai Lab investors own include NVIDIA (NVDA), Tesla (TSLA), Intel (INTC), Meta Platforms (META), Advanced Micro Devices (AMD), Baidu (BIDU) and Home Depot (HD).

Company Calendar

Last Earnings
8/07/2025
Today
8/28/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZLAB
CIK
1704292
Employees
1,869
Year Founded
N/A

Price Target and Rating

High Price Target
$75.00
Low Price Target
$36.10
Potential Upside/Downside
+73.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$257.10 million
Net Margins
-49.68%
Pretax Margin
-49.68%
Return on Equity
-27.32%
Return on Assets
-18.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.12
Quick Ratio
2.93

Sales & Book Value

Annual Sales
$427.80 million
Price / Sales
8.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.08 per share
Price / Book
4.60

Miscellaneous

Outstanding Shares
111,763,000
Free Float
106,220,000
Market Cap
$3.64 billion
Optionable
Optionable
Beta
1.03

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ZLAB) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners